Spinal pain adverse event reports that record this term

Kind of term: MedDRA preferred term
Plain meaning: spinal pain

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From June 2006 to June 2026, FDA received 11,554 adverse event reports that record the MedDRA preferred term Spinal pain. In plain words, the term means: spinal pain. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 588 reports in the 12 months to June 2026 and 588 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 896 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 588 (under 0.1%) record this term. Reports for female patients were 67% of the reports that record this term and 52.7% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Plain meaning

Spinal pain. The words are from the fixed dictionary of this site. They add nothing to a report.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 147 drug pages with 25 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Spinal pain name as a suspect product, in order of name
Drug	Class	Reports with this term
Abatacept	Selective T cell costimulation modulator	72
Acetaminophen		30
Aclasta		164
Actemra	Interleukin-6 receptor antagonist	101
Adalimumab	Tumor necrosis factor blocker	107
Afinitor	Kinase inhibitor	79
Alendronate sodium	Bisphosphonate	35
Amitriptyline		31
Amlodipine	Calcium channel blocker	83
Amlodipine besylate	Dihydropyridine calcium channel blocker	28
Anastrozole	Aromatase inhibitor	75
Arava	Antirheumatic agent	28
Aredia		31
Aspirin	Nonsteroidal anti-inflammatory drug	36
Atorvastatin		28
Aubagio	Pyrimidine synthesis inhibitor	29
Avastin	Vascular endothelial growth factor inhibitor	26
Avonex	Interferon beta	80
Baclofen	gamma-Aminobutyric acid-ergic agonist	57
Bleomycin	Cytoprotective agent	30
Boniva		30
Bortezomib	Proteasome inhibitor	28
Capecitabine	Nucleoside metabolic inhibitor	49
Carboplatin	Platinum-based drug	49
Celebrex	Nonsteroidal anti-inflammatory drug	49
Celecoxib	Nonsteroidal anti-inflammatory drug	43
Certolizumab pegol	Tumor necrosis factor blocker	51
Cimzia	Tumor necrosis factor blocker	46
Ciprofloxacin	Fluoroquinolone antibacterial	91
Citalopram	Serotonin reuptake inhibitor	26
Copaxone		62
Cortisone	Corticosteroid	26
Cosentyx	Interleukin-17A antagonist	625
Cyclophosphamide	Alkylating drug	95
Dacarbazine	Alkylating drug	34
Definity	Contrast agent for ultrasound imaging	50
Denosumab	RANK ligand inhibitor	42
Dexamethasone	Corticosteroid	129
Diazepam	Benzodiazepine	27
Diclofenac	Nonsteroidal anti-inflammatory drug	177
Diclofenac sodium	Nonsteroidal anti-inflammatory drug	74
Dilaudid	Opioid agonist	25
Diovan	Angiotensin 2 receptor blocker	25
Docetaxel	Microtubule inhibitor	74
Doxorubicin	Anthracycline topoisomerase inhibitor	53
Dupixent	Interleukin-4 receptor alpha antagonist	69
Eliquis	Factor Xa inhibitor	33
Enbrel	Tumor necrosis factor blocker	743
Entresto	Angiotensin 2 receptor blocker	29
Enzalutamide	Androgen receptor inhibitor	32
Erelzi		59
Etanercept	Tumor necrosis factor blocker	31
Etoposide	Topoisomerase inhibitor	56
Femara	Aromatase inhibitor	61
Folic acid		31
Forteo	Parathyroid hormone analog	267
Fosamax	Bisphosphonate	54
Fulvestrant	Estrogen receptor antagonist	88
Gabapentin	Anti-epileptic agent	90
Gilenya	Sphingosine 1-phosphate receptor modulator	132
Herceptin	HER2/neu receptor antagonist	29
Human immunoglobulin g	Human immunoglobulin G	26
Humira		945
Hydrochlorothiazide	Thiazide diuretic	31
Hydrochlorothiazide Valsartan		28
Hydroxychloroquine	Antimalarial	32
Ibrance	Kinase inhibitor	139
Ibuprofen	Nonsteroidal anti-inflammatory drug	110
Imbruvica	Kinase inhibitor	35
Inflectra	Tumor necrosis factor blocker	65
Infliximab	Tumor necrosis factor blocker	109
Ixazomib	Proteasome inhibitor	30
Kesimpta	CD20-directed cytolytic antibody	55
Kisqali	Kinase inhibitor	242
Leflunomide	Antirheumatic agent	27
Lenalidomide	Thalidomide analog	38
Letrozole	Aromatase inhibitor	175
Levofloxacin	Fluoroquinolone antibacterial	30
Lorazepam	Benzodiazepine	25
Losartan	Angiotensin 2 receptor blocker	32
Lyrica		163
Mabthera		50
Metformin	Biguanide	56
Methotrexate	Folate analog metabolic inhibitor	398
Methotrexate sodium	Folate analog metabolic inhibitor	103
Metoprolol	beta-Adrenergic blocker	42
Morphine	Opioid agonist	40
Naproxen	Nonsteroidal anti-inflammatory drug	62
Neulasta	Leukocyte growth factor	95
Nivolumab	Programmed death Receptor-1 blocking antibody	44
Ocrevus	CD20-directed cytolytic antibody	61
Orencia	Selective T cell costimulation modulator	67
Otezla	Phosphodiesterase 4 inhibitor	43
Oxycodone hydrochloride	Opioid agonist	49
OxyContin	Opioid agonist	30
Paclitaxel	Microtubule inhibitor	70
Pantoprazole	Proton pump inhibitor	64
Paracetamol		27
Pomalyst	Thalidomide analog	35
Prednisolone	Corticosteroid	102
Prednisone	Corticosteroid	156
Pregabalin		77
Procarbazine		31
Prolia	RANK ligand inhibitor	256
Quetiapine	Atypical antipsychotic	25
Ramipril	Angiotensin converting enzyme inhibitor	62
Rebif	Interferon beta	44
Reclast	Bisphosphonate	31
Remicade	Tumor necrosis factor blocker	96
Repatha	PCSK9 inhibitor	44
Revlimid	Thalidomide analog	165
Ribociclib	Kinase inhibitor	43
Rinvoq	Janus kinase inhibitor	121
Rituximab	CD20-directed cytolytic antibody	62
Rosuvastatin	HMG-CoA reductase inhibitor	28
Sandostatin LAR Depot		85
Secukinumab	Interleukin-17A antagonist	65
Simponi	Tumor necrosis factor blocker	96
Simvastatin	HMG-CoA reductase inhibitor	37
Skyrizi	Interleukin-23 antagonist	65
Soliris	Complement inhibitor	25
Stelara	Interleukin-12 antagonist	34
Sulfasalazine	Aminosalicylate	89
Sutent	Kinase inhibitor	31
Tacrolimus	Calcineurin inhibitor immunosuppressant	28
Tamoxifen		34
Tamsulosin		26
Tasigna	Kinase inhibitor	59
Tecfidera		82
Teriparatide	Parathyroid hormone analog	36
Torsemide	Loop diuretic	28
Tramadol		73
Trastuzumab	HER2/neu receptor antagonist	49
Truvada	Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	25
Tymlos		178
Tysabri	Integrin receptor antagonist	136
Ustekinumab	Interleukin-12 antagonist	26
Valsartan	Angiotensin 2 receptor blocker	70
Vinblastine		32
Vincristine		40
Xarelto	Factor Xa inhibitor	30
Xeljanz	Janus kinase inhibitor	217
Xgeva	RANK ligand inhibitor	53
Xolair	Anti-IgE	51
Xtandi	Androgen receptor inhibitor	35
Zoledronic acid	Bisphosphonate	88
Zometa		134

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 58 pharmacologic classes with 50 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Spinal pain name, in order of name
Class	Reports with this term
Alkylating drug	147
Aminosalicylate	89
Androgen receptor inhibitor	69
Angiotensin 2 receptor blocker	218
Angiotensin converting enzyme inhibitor	97
Anthracycline topoisomerase inhibitor	68
Anti-epileptic agent	111
Anti-IgE	62
Antimalarial	73
Antirheumatic agent	55
Aromatase inhibitor	337
Atypical antipsychotic	67
Benzodiazepine	80
beta-Adrenergic blocker	86
Biguanide	67
Bisphosphonate	245
Calcineurin inhibitor immunosuppressant	58
Calcium channel blocker	83
CD20-directed cytolytic antibody	215
Contrast agent for ultrasound imaging	50
Corticosteroid	469
Estrogen receptor antagonist	105
Factor Xa inhibitor	67
Fluoroquinolone antibacterial	123
Folate analog metabolic inhibitor	519
gamma-Aminobutyric acid-ergic agonist	62
Gonadotropin releasing hormone receptor agonist	53
HER2/neu receptor antagonist	118
HMG-CoA reductase inhibitor	119
Human immunoglobulin G	57
Insulin analog	64
Integrin receptor antagonist	169
Interferon beta	144
Interleukin-12 antagonist	60
Interleukin-17A antagonist	704
Interleukin-23 antagonist	65
Interleukin-4 receptor alpha antagonist	75
Interleukin-6 receptor antagonist	119
Janus kinase inhibitor	382
Kinase inhibitor	829
Leukocyte growth factor	111
Microtubule inhibitor	144
Nonsteroidal anti-inflammatory drug	601
Nucleoside metabolic inhibitor	94
Opioid agonist	299
Parathyroid hormone analog	303
PCSK9 inhibitor	50
Platinum-based drug	76
Programmed death Receptor-1 blocking antibody	102
Proteasome inhibitor	101
Proton pump inhibitor	139
RANK ligand inhibitor	351
Selective T cell costimulation modulator	139
Serotonin reuptake inhibitor	69
Sphingosine 1-phosphate receptor modulator	137
Thalidomide analog	255
Topoisomerase inhibitor	59
Tumor necrosis factor blocker	1,372

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Spinal pain, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Spinal pain
Age	Reports	Share
Under 2	2	under 0.1%
2 to 11	22	0.2%
12 to 17	57	0.5%
18 to 44	1,581	13.7%
45 to 64	3,486	30.2%
65 to 74	1,608	13.9%
75 and over	1,153	10%
Age not given	3,645	31.5%

Sex of the patient in the reports that record Spinal pain
Sex	Reports	Share
Female	7,740	67%
Male	3,152	27.3%
Unknown or not given	662	5.7%

Age and sex are as the report gives them. 43.3% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Spinal pain: adverse event reports that record this term. https://reportedreactions.com/reaction/spinal-pain/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Spinal pain mean in an adverse event report?

In plain words: spinal pain. It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page